A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs). According to research published in the September issue of the ...
Sep 28, 2022
0
0
Artificial intelligence (AI) is showing significant promise in medical imaging. To translate this promise to reality requires rigorous evaluation of these algorithms.
Sep 13, 2022
0
24
In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as compared to imaging with CT ...
Sep 7, 2022
0
19
Researchers have developed a noninvasive method to identify a potential cause of hypertension with a drastic reduction in radiation exposure, a study shows.
Jul 13, 2022
0
5
In a prospective study of young, lean adults, PET/CT imaging revealed that higher levels of active brown adipose tissue (also known as "brown fat") are more prevalent in individuals who exhibit very early indications of metabolic ...
May 6, 2022
0
25
A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive impairment—are ultimately reversible, according to new research summarized by the Journal of Nuclear Medicine. The ...
Mar 17, 2022
0
101
New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk classification system that groups prostate cancer patients based on their risk of recurrence. Prostate-specific membrane antigen ...
Jan 21, 2022
0
17
By combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, according to research published in the January issue of The Journal of Nuclear Medicine. ...
Jan 11, 2022
0
40
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and peer medical groups have issued appropriate use criteria (AUC) for prostate-specific membrane antigen (PSMA) PET imaging. The criteria, published in the January ...
Jan 7, 2022
0
4
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients. The first-in-human ...
Nov 23, 2021
0
7
